Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Lung Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Neoplasm Metastasis 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Kidney Neoplasms 3Breast Neoplasms 3Brain Neoplasms 3Urogenital Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Carcinoma, Squamous Cell 2Carcinoma, Large Cell 2Adenocarcinoma of Lung 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1Tonsillar Neoplasms 1Stomach Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Neoplasms, Plasma Cell 1Neoplasm Recurrence, Local 1Multiple Myeloma 1

Interventions

pembrolizumab 2motexafin gadolinium 1Taxes 1Pemetrexed 1Paclitaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Hypopharyngeal Neoplasms × motexafin gadolinium × Clear all
NCT00080028 2007-05-08

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Pharmacyclics LLC.

Phase 1 Terminated
18 enrolled
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms, Tonsillar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡